Pyelonephritis
📧 Sign up to get email alerts when something new happens for Pyelonephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Effect of Acetylcysteine in Pediatric Acute Pyelonephritis. [Phase 2]
Clinical trial status update indicating the Phase 2 study of acetylcysteine for acute pyelonephritis in pediatric patients has been complete…
-
FDA approval · 2016-04-12FDA Approved: CEFUROXIME — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Cefuroxime, adding an additional approved use/formulation under t…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) [Phase 3]
Phase 3 trial comparing ceftazidime-avibactam to doripenem followed by oral therapy for adults with complicated urinary tract infections, in…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) [Phase 3]
Phase 3 trial comparing ceftazidime-avibactam to doripenem followed by oral therapy for hospitalized adults with complicated UTIs, including…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli [Phase 2]
A Phase 2 clinical trial update evaluating the combination of sitafloxacin and ertapenem for acute pyelonephritis caused by Escherichia coli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication [Phase 4]
Phase 4 clinical trial assessing whether six patient information leaflets improve doctor-patient communication; the study by Floralis is com…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria [NA]
A clinical trial compares antibiotic treatment to no therapy for asymptomatic bacteriuria in kidney transplant recipients; the current statu…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: A Randomized Controlled Trial on Antibiotic Prophylaxis in Children With Vesico-Ureteral Reflux [Phase 4]
This trial update reports the completion of a randomized controlled Phase 4 study evaluating antibiotic prophylaxis in children with vesicou…
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis
Clinical trial NCT01641029 evaluated antimicrobial resistance among community-associated uropathogens in emergency department patients with …
-
CLINICAL_TRIALS withdrawal · 2015-01-16Clinical Trial Update: Antibiotic Prophylaxis in Children With Pyelonephritis [Phase 3]
A Phase 3 trial evaluating antibiotic prophylaxis in children with pyelonephritis has been withdrawn, with sponsor listed as the University …
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis [Phase 3]
A Phase 3 trial comparing CXA-201 versus levofloxacin in complicated urinary tract infection with pyelonephritis has completed and posted re…
-
FDA approval · 2014-11-08FDA Approved: LEVOFLOXACIN — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved a supplemental application for Levofloxacin submitted by Sagent Pharmaceuticals, approving changes to the generic labeling …
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Treatment's Duration of Acute Uncomplicated Pyelonephritis [Phase 4]
Phase 4 clinical trial update announcing the completion of a study evaluating the optimal duration of treatment for acute uncomplicated pyel…
-
CLINICAL_TRIALS withdrawal · 2014-10-02Clinical Trial Update: Bacterial and Host Genetic Risk Factors in Acute Pyelonephritis
A clinical trial exploring bacterial and host genetic risk factors in acute pyelonephritis was withdrawn from the registry.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in Children [Phase 3]
A Phase 3 clinical trial is evaluating whether oral omega-3 can reduce kidney scarring in children after acute pyelonephritis. The study sta…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections [Phase 3]
A Phase 3 safety and tolerability trial in hospitalized children compared doripenem with cefepime for complicated urinary tract infections a…
-
FDA approval · 2014-03-05FDA Approved: CIPROFLOXACIN — Original Application (Chartwell RX, LLC)
FDA approved the original application for ciprofloxacin (generic) by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: L-carnitine on the Prevention of Renal Scarring in Acute Pyelonephritis [Phase 3]
This document updates a Phase 3 clinical trial evaluating L-carnitine for the prevention of renal scarring in acute pyelonephritis. The stud…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Prospective Study in the Emergency [Phase 2]
A Phase 2 prospective emergency study sponsored by Assistance Publique - Hôpitaux de Paris for pyelonephritis has been terminated.
-
FDA approval · 2013-06-05FDA Approved: LEVOFLOXACIN — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's Original Application for levofloxacin (generic), granting clearance for a generic version of th…
-
FDA approval · 2012-03-30FDA Approved: LEVOFLOXACIN — Original Application (Chartwell RX, LLC)
FDA approved an original ANDA for Levofloxacin, a generic antibiotic, submitted by Chartwell RX, LLC. The approval enables a generic version…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Short-term Antibiotic Therapy for Pyelonephritis in Childhood [Phase 3]
This clinical trial update notes the termination of a Phase 3 study evaluating short-term antibiotic therapy for pyelonephritis in children.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis. [Phase 3]
Phase 3 trial comparing levofloxacin to ciprofloxacin for complicated urinary tract infection and acute pyelonephritis has completed. The st…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis [Phase 3]
A completed Phase 3 trial evaluating doripenem for complicated urinary tract infections and pyelonephritis.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis [Phase 3]
Phase 3 evaluation of Doripenem for complicated lower urinary tract infection and pyelonephritis has been completed.